FDA-approved drugs in 2022: A brief outline

FDA-approved drugs in 2022: A brief outline

Bibliographic Details
Main Author:	Haitham Ahmed Al-Madhagi
Format:	Article
Language:	English
Published:	Elsevier 2023-03-01
Series:	Saudi Pharmaceutical Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S1319016423000154

Similar Items

FDA Approvals of Biologics in 2022
by: Alexander C. Martins, et al.
Published: (2023-05-01)

Synthesis and clinical application of new drugs approved by FDA in 2022
by: Jing-Yi Zhang, et al.
Published: (2023-09-01)

Chemistry and Pharmacology of Fluorinated Drugs Approved by the FDA (2016–2022)
by: Ghulam Shabir, et al.
Published: (2023-08-01)

FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022
by: Carla Rizzo, et al.
Published: (2023-04-01)

The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of Molecules
by: Beatriz G. de la Torre, et al.
Published: (2023-01-01)

Structure based virtual screening and molecular simulation study of FDA-approved drugs to inhibit human HDAC6 and VISTA as dual cancer immunotherapy
by: Muhammad Shahab, et al.
Published: (2023-09-01)

FDA-Approved Small Molecules in 2022: Clinical Uses and Their Synthesis
by: Davide Benedetto Tiz, et al.
Published: (2022-11-01)

Design and synthesis of fluorine aromatic scaffolds containing drugs approved by the US FDA from 2002 to 2022
by: Pengfei Xu, et al.
Published: (2024-01-01)

Forward or Backward: Lessons Learned from Small Molecule Drugs Approved by FDA from 2012 to 2022
by: Mingxiao Gu, et al.
Published: (2023-12-01)

Targeted drug approvals in 2023: breakthroughs by the FDA and NMPA
by: Lang Zheng, et al.
Published: (2024-02-01)

Quantitative analysis on the characteristics of targets with FDA approved drugs
by: Meena K. Sakharkar, Peng Li, Zhaowei Zhong, Kishore R. Sakharkar
Published: (2008-01-01)

Synchrony 2022: Roundtable Discussion on the Pathways and the Challenges of Getting Medications FDA Approved
by: Gabriel Belfort, et al.
Published: (2023-04-01)

Ebanga™: The most recent FDA-approved drug for treating Ebola
by: Elahe Taki, et al.
Published: (2023-03-01)

FDA-Approved Drugs for Hematological Malignancies—The Last Decade Review
by: Aleksandra Sochacka-Ćwikła, et al.
Published: (2021-12-01)

An Insight into FDA Approved Antibody-Drug Conjugates for Cancer Therapy
by: Juliana T. W. Tong, et al.
Published: (2021-09-01)

DRUG SAFETY ASSESSMENT FOR CENOBAMATE A RECENTLY FDA-APPROVED ANTIEPILEPTIC
by: Beatrice Radu, et al.
Published: (2023-10-01)

A review of FDA approved drugs and their formulations for the treatment of breast cancer
by: Mohini Chaurasia, et al.
Published: (2023-07-01)

Drug Delivery Systems as a Strategy to Improve the Efficacy of FDA-Approved Alzheimer’s Drugs
by: Débora Nunes, et al.
Published: (2022-10-01)

Shape-based reprofiling of FDA-approved drugs for the H₁ histamine receptor.
by: Vasudevan, SR, et al.
Published: (2012)

Anti-Cancer Drugs Targeting Protein Kinases Approved by FDA in 2020
by: Jonas Cicenas, et al.
Published: (2021-02-01)

Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials
by: Shigeto Nishikawa, et al.
Published: (2023-01-01)

Pharmacogenomic Biomarkers in US FDA-Approved Drug Labels (2000–2020)
by: Jeeyun A. Kim, et al.
Published: (2021-03-01)

2020 FDA/EMA approvals for new immunotherapy drug technologies and applications
by: Maryam Monajati, et al.
Published: (2021-06-01)

Exploring anti-malarial potential of FDA approved drugs: an in silico approach
by: Gayatri Ramakrishnan, et al.
Published: (2017-07-01)

An insider's perspective on FDA approval of aducanumab
by: Yaning Wang
Published: (2023-04-01)

An overview of FDA-approved vaccines & their innovators
by: Rebekah H. Griesenauer, et al.
Published: (2017-12-01)

Why did the FDA approve these advertisements?
by: David Oaks
Published: (2006-02-01)

FDA approved ready to use phenylephrine
by: Pradeep Kumar Bhatia, et al.
Published: (2021-01-01)

A systematic screen of FDA-approved drugs for inhibitors of biological threat agents.
by: Peter B Madrid, et al.
Published: (2013-01-01)

FDA Approved Drug Library Screening Identifies Robenidine as a Repositionable Antifungal
by: Yikun Mei, et al.
Published: (2020-06-01)

Brief outline of the Molodenskij theory/
by: Vanicek, Petr, 1935-
Published: (1974)

2022 FDA TIDES (Peptides and Oligonucleotides) Harvest
by: Othman Al Musaimi, et al.
Published: (2023-02-01)

Synthetic Approaches to Piperazine-Containing Drugs Approved by FDA in the Period of 2011–2023
by: Maria Novella Romanelli, et al.
Published: (2023-12-01)

Harnessing machine learning to find synergistic combinations for FDA-approved cancer drugs
by: Tarek Abd El-Hafeez, et al.
Published: (2024-01-01)

The Pharmaceutical Industry in 2023: An Analysis of FDA Drug Approvals from the Perspective of Molecules
by: Beatriz G. de la Torre, et al.
Published: (2024-01-01)

The Pharmaceutical Industry in 2020. An Analysis of FDA Drug Approvals from the Perspective of Molecules
by: Beatriz G. de la Torre, et al.
Published: (2021-01-01)

Virtual Screening of FDA-Approved Drugs for Enhanced Binding with Mitochondrial Aldehyde Dehydrogenase
by: Boqian Zhou, et al.
Published: (2022-12-01)

Targeted Therapy for Cancers: From Ongoing Clinical Trials to FDA-Approved Drugs
by: Ha Yeong Choi, et al.
Published: (2023-09-01)

The Pharmaceutical Industry in 2021. An Analysis of FDA Drug Approvals from the Perspective of Molecules
by: Beatriz G. de la Torre, et al.
Published: (2022-02-01)

Hydrogel-Based Pre-Clinical Evaluation of Repurposed FDA-Approved Drugs for AML
by: Jenna R. James, et al.
Published: (2023-02-01)